October 1, 2021

Bayer Recalls Over-the-Counter Anti-Fungal Sprays

Read More
October 1, 2021

Brand Medications with Generic Alternatives Anticipated to be Approved in November

Read More
September 29, 2021

Livmarli Becomes First FDA-Approved Drug for Rare Liver Disease

Read More
September 28, 2021

Qulipta Granted FDA Approval to Prevent Migraines

Read More
September 28, 2021

Erbitux Approved for Use with Braftovi to Treat Colorectal Cancer

Read More
September 28, 2021

Eli Lilly to Reduce List Prices for Generic Insulins in 2022

Read More
September 22, 2021

Jakafi Now Indicated to Treat Chronic Graft vs. Host Disease

Read More
September 21, 2021

Opzelura Cream Approved to Treat Atopic Dermatitis

Read More
July 23, 2021

Dalvance Now Indicated to Treat Acute Bacterial Skin and Skin Structure Infections in Children as Well as Adults

Read More
June 15, 2021

Rezipres Approved to Treat Hypotension in Patients Under Anesthesia

Read More
June 11, 2021

Two Lots of Metformin Recalled Due to NDMA

Read More
May 28, 2021

Zipsor Indication Expanded to Include Adolescent Patients

Read More